José Ferreira Sarmento‐Neto

José Ferreira Sarmento‐Neto

Auto-generated profile, based on publicly available information

José Ferreira Sarmento‐Neto

Departamento de Quimica, Universidade Federal da Paraiba, Joao Pessoa, PB, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Photochemistry and Photobiology C: Photochemistry Reviews
Verified
Journal Article
Closed access
TSTiago H.S. Souza
Tiago H.S. Souza
JSJosé F. Sarmento-Neto
José F. Sarmento-Neto
SSSueden Oliveira de Souza
Sueden Oliveira de Souza
BRBruno L. Raposo
Bruno L. Raposo
BSBruna P. Silva
Bruna P. Silva
AFAdriana Fontes
Adriana Fontes

27 March 2018 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
CAC. G. Andrade
C. G. Andrade
RFRegina Celia Bressan Queiroz Figueiredo
Regina Celia Bressan Queiroz Figueiredo
KRK. R. C. Ribeiro
K. R. C. Ribeiro
LSL. I. O. Souza
L. I. O. Souza
JSJ. F. Sarmento-Neto
J. F. Sarmento-Neto
AFAdriana Fontes
Adriana Fontes
Leishmaniasis is a neglected disease present in more than 88 countries. The currently adopted chemotherapy faces challenges related to side effects and the development of resistance. Photodynamic therapy (PDT) is emerging as a therapeutic modality for cutaneous leishmaniasis. Zn(II) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin (ZnTE-2-PyP4+, ZnP) is a cationic, water-soluble, zinc porphyrin-based photosensitizer whose photodynamic effect on Leishmania braziliensis was analyzed by evaluating the number of visibly undamaged and motile cells, cell membrane integrity, mitochondrial membrane potential, and ultrastructural damage. Treatment of parasites with ZnP and light induced damage in up to 90% of L. braziliensis promastigote cells. Propidium iodide labeling suggested the loss of plasma membrane integrity. In samples treated with ZnP and light, a hyperpolarization of the mitochondrial membrane potential was also observed. Ultrastructural evaluation of promastigotes after photodynamic treatment indicated a loss of cytoplasmic material and the presence of vacuoles. Scanning electron microscopy showed wrinkling of the plasma membrane and a reduced cell volume. Additionally, the number of amastigotes per macrophage was reduced by about 40% after photodynamic application. The treatment showed no considerable toxicity against mammalian cells. Therefore, the results indicated that PDT associated with ZnTE-2-PyP4+ represents a promising alternative to cutaneous leishmaniasis treatment.

25 May 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
SSSueden Oliveira de Souza
Sueden Oliveira de Souza
BRBruno L. Raposo
Bruno L. Raposo
JSJosé F. Sarmento-Neto
José F. Sarmento-Neto
JRJulio Reboucas
Julio Reboucas
DMDanielle Patrícia Cerqueira Macêdo
Danielle Patrícia Cerqueira Macêdo
AFAdriana Fontes
Adriana Fontes
Candida albicans is the main cause of superficial candidiasis. While the antifungals available are defied by biofilm formation and resistance emergence, antimicrobial photodynamic inactivation (aPDI) arises as an alternative antifungal therapy. The tetracationic metalloporphyrin Zn(II) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin (ZnTnHex-2-PyP4+) has high photoefficiency and improved cellular interactions. We investigated the ZnTnHex-2-PyP4+ as a photosensitizer (PS) to photoinactivate yeasts and biofilms of C. albicans strains (ATCC 10231 and ATCC 90028) using a blue light-emitting diode. The photoinactivation of yeasts was evaluated by quantifying the colony forming units. The aPDI of ATCC 90028 biofilms was assessed by the MTT assay, propidium iodide (PI) labeling, and scanning electron microscopy. Mammalian cytotoxicity was investigated in Vero cells using MTT assay. The aPDI (4.3 J/cm2) promoted eradication of yeasts at 0.8 and 1.5 µM of PS for ATCC 10231 and ATCC 90028, respectively. At 0.8 µM and same light dose, aPDI-treated biofilms showed intense PI labeling, about 89% decrease in the cell viability, and structural alterations with reduced hyphae. No considerable toxicity was observed in mammalian cells. Our results introduce the ZnTnHex-2-PyP4+ as a promising PS to photoinactivate both yeasts and biofilms of C. albicans, stimulating studies with other Candida species and resistant isolates.

1 July 2021 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
TSTiago H.S. Souza
Tiago H.S. Souza
CACamila G. Andrade
Camila G. Andrade
FCFernanda Viana Cabral
Fernanda Viana Cabral
JSJosé F. Sarmento-Neto
José F. Sarmento-Neto
JRJulio Reboucas
Julio Reboucas
AFAdriana Fontes
Adriana Fontes

21 March 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ABAndrezza M. Barbosa
Andrezza M. Barbosa
JSJosé F. Sarmento-Neto
José F. Sarmento-Neto
JFJosé E. R. Menezes Filho
José E. R. Menezes Filho
IJItamar C. G. Jesus
Itamar C. G. Jesus
DSDiego Santos Souza
Diego Santos Souza
EGEnéas R. Gomes
Enéas R. Gomes
Background. Cardiomyopathies remain among the leading causes of death worldwide, despite all efforts and important advances in the development of cardiovascular therapeutics, demonstrating the need for new solutions. Herein, we describe the effects of the redox-active therapeutic Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, AEOL10113, BMX-010 (MnTE-2-PyP5+), on rat heart as an entry to new strategies to circumvent cardiomyopathies. Methods. Wistar rats weighing 250-300 g were used in both in vitro and in vivo experiments, to analyze intracellular Ca2+ dynamics, L-type Ca2+ currents, Ca2+ spark frequency, intracellular reactive oxygen species (ROS) levels, and cardiomyocyte and cardiac contractility, in control and MnTE-2-PyP5+-treated cells, hearts, or animals. Cells and hearts were treated with 20 μM MnTE-2-PyP5+ and animals with 1 mg/kg, i.p. daily. Additionally, we performed electrocardiographic and echocardiographic analysis. Results. Using isolated rat cardiomyocytes, we observed that MnTE-2-PyP5+ reduced intracellular Ca2+ transient amplitude, without altering cell contractility. Whereas MnTE-2-PyP5+ did not alter basal ROS levels, it was efficient in modulating cardiomyocyte redox state under stress conditions; MnTE-2-PyP5+ reduced Ca2+ spark frequency and increased sarcoplasmic reticulum (SR) Ca2+ load. Accordingly, analysis of isolated perfused rat hearts showed that MnTE-2-PyP5+ preserves cardiac function, increases SR Ca2+ load, and reduces arrhythmia index, indicating an antiarrhythmic effect. In vivo experiments showed that MnTE-2-PyP5+ treatment increased Ca2+ transient, preserved cardiac ejection fraction, and reduced arrhythmia index and duration. MnTE-2-PyP5+ was effective both to prevent and to treat cardiac arrhythmias. Conclusion. MnTE-2-PyP5+ prevents and treats cardiac arrhythmias in rats. In contrast to most antiarrhythmic drugs, MnTE-2-PyP5+ preserves cardiac contractile function, arising, thus, as a prospective therapeutic for improvement of cardiac arrhythmia treatment.

24 September 2026 in Lasers in Surgery and Medicine
Verified
Journal Article
Open access
KCKammila Martins Nicolau Costa
Kammila Martins Nicolau Costa
JSJosé Ferreira Sarmento‐Neto
José Ferreira Sarmento‐Neto
JRJulio Reboucas
Julio Reboucas
RMRicardo Olímpio de Moura
Ricardo Olímpio de Moura
JCJohn F. Callan
John F. Callan
João Augusto Oshiro-JúniorJoão Augusto Oshiro-Júnior
João Augusto Oshiro-Júnior
Objectives: This study aims to synthesize and characterize lipid nanosystems (liposomes) for the incorporation of a Zn(II) porphyrin derivative, Zn(II) meso‐tetrakis(N‐n‐hexylpyridinium‐2‐yl)porphyrin (ZnTnHex‐2‐PyP4+, ZnPH), intending to employ an alternative method of treatment, such as photodynamic therapy (PDT), for breast cancer (BC). Methods: The system was synthesized using the lipid film hydration technique and characterized by dynamic and electrophoretic light scattering, nanoparticle tracking analysis, and microscopic analysis, in addition to an assay to detect reactive oxygen species (ROS) generation (DPBF) and in vitro assays assessing release percentage and cell viability, in conjunction with an in vivo systemic toxicity study using an Artemia salina model. Results: The liposomes exhibited particle diameters ranging from 92.57 to 112.17 nm, a polydispersity index between 0.22 and 0.28, and a zeta potential between −10.56 and −15.33 mV. The ROS generation assay resulted in a quantum yield of 0.19. Cell viability assays showed viability below 35% in 2D models, with confirmation in 3D models. In vitro release studies indicated a modified profile following encapsulation, and in vivo studies using acute toxicity models in A. salina suggested that the formulation is non‐toxic. Conclusion: The results demonstrate that the nanostructured systems show promising performance, reinforcing the potential of stimulus‐responsive therapies in the treatment of BC.